You are Rodrigo Salamanca-Maluenda, 52, Global Trade Compliance Director at Talleres Iberindustrial, a Madrid-headquartered Spanish precision-machining mid-cap. Yesterday the head of sales walked a €14M centrifuge order into your office and said: "Tell me this is fine."
The situation
Talleres Iberindustrial: €310M revenue, 1,140 staff, three plants in Castilla y León. Family-controlled by the third-generation Solchaga family. Product line: large-scale industrial centrifuges, separators, and reactor vessels for chemical, dairy, pharmaceutical, and energy customers. Quiet international order book — ~38% exports — built mostly through regional distributors. Margins are good; the family is risk-averse.
The order. A Turkish distributor you have worked with for nine years (Anadolu Endüstri Pazarlama A.Ş., based in Istanbul) has placed a €14M order for six PCV-7200 centrifuges. The end-use certificate names Daru Bandi Pars Co., a pharmaceutical-packaging plant near Isfahan, Iran. The stated purpose: separation of generic-medicine APIs. The PCV-7200 is a separator under EU Council Regulation 2021/821 (the dual-use regulation), Annex I category 2B350.b — a controlled item because configured differently it can serve as a corrosion-resistant separator for sulphur mustard precursor chemicals, with theoretical relevance to a chemical-weapons programme. Daru Bandi Pars does not appear on any EU, UN, OFAC, or HM Treasury sanctions list. Its ultimate beneficial owner is filed in Iran's commercial registry as a private holding controlled by two named individuals; neither is listed. Iran itself remains under partial EU sanctions and full secondary US sanctions. Your sales VP, Bárbara Marraco-Lasarte, has flown to Istanbul and back twice for this order and reads the contract as a "Turkey-to-Turkey" sale on paper.